НовостиBenzingaMorgan Stanley Maintains Overweight on BeOne Medicines, Raises Price Target to $476 Morgan Stanley Maintains Overweight on BeOne Medicines, Raises Price Target to $476 Benzinga 2026.11.13 17:58 (GMT+0) Открыть на Benzinga Другие новости